antihypertensive and monoamine oxidase inhibitory activity of some azacycloalkyl-substituted benzaldehyde hydrazone derivatives.
D000284:Administration, Oral; D000818:Animals; D000959:Antihypertensive Agents; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000201:enzymology / Q000378:metabolism; D002415:Cats; D004285:Dogs; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D005730:Ganglionic Blockers; D006977:Hypertension, Renal / Q000188:drug therapy; D007036:Hypothermia, Induced; D007275:Injections, Intravenous; D008099:Liver / Q000187:drug effects; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism; D009541:Nictitating Membrane / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D010659:Phenylhydrazines / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D010879:Piperazines / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013997:Time Factors
D000959:Antihypertensive Agents; D005730:Ganglionic Blockers; D008996:Monoamine Oxidase Inhibitors; D010659:Phenylhydrazines; D010879:Piperazines; D012701:Serotonin; D004298:Dopamine; D009638:Norepinephrine